Form 8-K - Current report:
SEC Accession No. 0001437749-24-033922
Filing Date
2024-11-07
Accepted
2024-11-07 16:12:17
Documents
16
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opk20241029_8k.htm   iXBRL 8-K 28774
2 EXHIBIT 99.1 ex_744709.htm EX-99.1 100267
7 ex_744709img001.jpg GRAPHIC 3748
  Complete submission text file 0001437749-24-033922.txt   266307

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA opk-20241107.xsd EX-101.SCH 3401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20241107_def.xml EX-101.DEF 11421
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20241107_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20241107_pre.xml EX-101.PRE 11581
18 EXTRACTED XBRL INSTANCE DOCUMENT opk20241029_8k_htm.xml XML 2816
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 241435812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)